Key takeaways: 1、Everest will pay up to $150 million or more to potentially bring an mRNA vaccine being developed by Canada’s Providence Therapeutics to China 2、Deal comes as Beijing appears increasingly receptive to mRNA vaccines, even though Providence’s jabs have yet to be approved in its home Canada market By Richard Barbarossa China may still be without a Covid-19 vaccine based on messenger RNA (mRNA) technology, generally considered the most effective for preventing infections. But many are racing to bring such vaccines to the country, even as the latest official data shows 1 billion Chinese have now been vaccinated using several homegrown shots based on older technologies. That crowd gained another member last week when cancer and autoimmune disorder drug startup Everest Medici